Dec 26 (Reuters) -
AUSPERBIO SECURES $73 MILLION IN SERIES B FINANCING TO ADVANCE FUNCTIONAL CURE FOR CHRONIC HEPATITIS B
AUSPERBIO THERAPEUTICS- ROUND WAS LED BY HANKANG CAPITAL, WITH PARTICIPATION FROM SHERPA CAPITAL, CDH INVESTMENTS
Source text: ID:nPn4NzlpBa
((Reuters.Briefs@thomsonreuters.com;))